Type 2 diabetes, resulting from a progressive, non-autoimmune reduction in β-cell insulin secretion, often amid insulin resistance and metabolic syndrome, represents 90-95% of all diabetes cases. The gene discussed is INS; the disease is metabolic syndrome.